Tech Company Financing Transactions
MyoScience Funding Round
On 9/13/2013, MyoScience secured $25 million in Series E funding from Accuitive Medical Ventures, American Equities Overseas and De Novo Ventures.
Transaction Overview
Company Name
Announced On
9/13/2013
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series E
Investors
Accuitive Medical Ventures (Thomas Weldon)
De Novo Ventures (Richard Ferrari)
Proceeds Purpose
The company will use the funding proceeds for expanding its geography and indications to recognize the full potential of their platform technology.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
46400 Fremont Blvd.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
MyoScience is developing an innovative, hand held medical device designed to be used for facial rejuvenation. It is currently being evaluated in clinical studies for the treatment of facial wrinkles like frown lines between the brow, forehead lines, and crow's feet.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Still
Executive Vice President
David Derminio
VP - Finance
Andrew Jones
VP - Human Resources
Patti Camarena
VP - Marketing
Kris Kumar
VP - Operations
Greg Takaki
VP - R & D
Eric Johanson
VP - Regulatory Affairs
Kent Jones
Browse more venture capital transactions:
Prev: 9/13/2013: Crown Bioscience venture capital transaction
Next: 9/13/2013: Insightly venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs